Recent Headlines
Philadelphia Athletes Complete 8.5k for Kids with Brain Tumors
The City of Brotherly Love welcomed about 750 walkers and runners on Sept. 19 for the Philadelphia Starry Night 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $47,974 to help fund the foundation’s lifesaving research and life-changing family... - September 23, 2015 - Pediatric Brain Tumor Foundation
Golden State Motorcyclists Ride for Kids with Brain Tumors
More than 330 motorcyclists gathered for children battling brain tumors at the San Diego Ride for Kids event over the weekend. As of ride time, this motorcycle event had raised $35,912 to support the Pediatric Brain Tumor Foundation. The event at Mira Costa College in Cardiff honored four local... - September 23, 2015 - Pediatric Brain Tumor Foundation
Matrix Medical to Attend NASS 2015
Matrix IT, Medical Tracking Systems has announced plans to attend the 2015 NASS 2015 Conference, in Chicago, Illinois. NASS is a conference specifically targeted for interested stakeholders in spinal orthopedic solutions. As the FDA UDI Final Rule is fast approaching, Matrix IT is planning on... - September 20, 2015 - Matrix Medical Tracking Systems
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Motorcyclists from Coast to Coast Ride for Kids with Brain Tumors
Motorcyclists from Birmingham, Philadelphia and Puget Sound hit the road for children battling brain tumors during Ride for Kids events over the weekend. These family-friendly motorcycle events, held in Leeds, Ala., Phoenixville, Pa., Carnation, Wash., raised more than $150,000 to support the... - September 16, 2015 - Pediatric Brain Tumor Foundation
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
Clinical Imaging Board Publishes Guidance to Address Concerns in Relation to Patient Identification
The CIB published guidance and recommendations on patient identification, aimed at ensuring that the right patients always undergo the right diagnostic imaging procedures (scans, x-rays, etc). - September 07, 2015 - Insititute of Physics and Engineering in Medicine
NASH Drugs Market, 2015-2025
The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis
Protein Expression Systems Market: Current Landscape and Future Opportunities
Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis
Epitope Diagnostics Introduces Novel Fecal NGAL Specific ELISA Kit for Inflammatory Bowel Disease
Epitope Diagnostics introduces its novel fecal neutrophil gelatinase-associated lipocalin (NGAL) ELISA kit. This is the first commercial kit that is developed for measurement of NGAL levels in human stool sample. Fecal NGAL is potentially a better marker than those currently used in clinical practice. - September 01, 2015 - Epitope Diagnostics, Inc.
New England, North Carolina Motorcyclists Hit Road for Kids
From the mountains of North Carolina to history-rich sites of Massachusetts, motorcyclists hit the road over the weekend for kids battling brain tumors. These family-friendly Ride for Kids events, held in Asheville, N.C., and Framingham, Mass., raised $84,236 to support the Pediatric Brain Tumor... - August 27, 2015 - Pediatric Brain Tumor Foundation
Oral Cancer Awareness Key to Survival
Scripps Oral Pathology Service (SOPS) offers CE course in Del Mar, CA, "Oral Pathology: From Differential Diagnosis to Biopsy." - August 26, 2015 - Scripps Oral Pathology Service
Speaking of NEC Podcast Featuring Expert Parent Laura Martin Launches August 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - August 26, 2015 - The Morgan Leary Vaughan Fund, Inc.
ALPCO Releases New STELLUX® Chemiluminescent Adiponectin ELISAs
ALPCO has launched its new STELLUX® Chemiluminescent Total Adiponectin and HMW Adiponectin ELISAs. - August 25, 2015 - ALPCO
Molecular Innovations, Inc. Issued U.S. Patent for Human Prorenin ELISA Kit
Molecular Innovations, Inc. has been issued United States Patent Number 9,085,795 for its unique and novel “Human Prorenin ELISA Kit.” - August 23, 2015 - Molecular Innovations
Anaemia Screening Digital Health Tech Takes Top Prize in 2015 MedTech’s Got Talent
Eyenaemia won an additional $40,000 cash prize to accelerate their anaemia screening platform toward commercialisation after beating out four other top teams at the closed-door Investor Boardroom Pitch, the final stage of the 2015 round of MedTech’s Got Talent. - August 21, 2015 - STC
Research Conducted by Dr. Antonio Medina at MIT Demonstrates That Glasses Worsen Eyesight
The latest research published in print this month demonstrates that wearing glasses worsens nearsightedness (myopia). Graefes Arch Clin Exp Ophthalmol (2015) 253:1273-1277. Medina’s feedback model for emmetropization predicts that correction of myopes aggravates their condition and myopia... - August 19, 2015 - Antonio Medina
St. Louis Motorcyclists Rev It Up at Ride for Kids
St. Louis motorcyclists gathered over the weekend to honor 11 local brain tumor survivors at the Pediatric Brain Tumor Foundation's Ride for Kids event. The family-friendly event, held at St. Charles Community College in Cottleville, raised $46,290 to support the foundation's lifesaving research... - August 19, 2015 - Pediatric Brain Tumor Foundation
Hometown Urgent Care to Open Third Clinic Off I-94
Hometown Urgent Care to open third clinic off I-94. Expansion makes Hometown largest urgent care provider for Kalamazoo and Portage residents. - August 17, 2015 - Hometown Urgent Care
Matrix Medical Announces Strategic Partner Plan with Key Hospitals
Matrix Medical announces new strategic partners for the Tractus product line. The product plans to solve the FDA direct part marking requirement pursuant to the FDA Final Rule pertaining to the UDI requirement. - August 17, 2015 - Matrix Medical Tracking Systems
NanoHybrids Launches Gold Nanoparticles Custom Designed to Improve Lateral Flow Quality and Reproducibility
Careful selection of indicator particles is absolutely critical to the performance of any lateral flow assay. NanoHybrids’ new line of monodisperse gold nanoparticles can enable the development of lateral flow assays that meet the highest specifications of the industry, particularly with respect to sensitivity and reproducibility. - August 16, 2015 - NanoHybrids
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
Matrix Medical Releases TRACTUS Video, World's First Sterile Scanner Showcased
Matrix Medical, a Wisconsin company, has unveiled the first ever sterile scanner, TRACTUS. A video has been released showcasing how the scanner can easily scan 2D data matrix codes in the sterile field. - August 09, 2015 - Matrix Medical Tracking Systems
Dr Nader N Youssef Appointed Chief Medical Officer of electroCore
Dr Nader N Youssef has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore. He was previously Executive Director GI Global Clinical Development... - August 09, 2015 - electroCore
Fertility Preservation Network Welcomes Huntington, West Virginia Area Facility
Program greatly extends access to fertility preservation services. - August 07, 2015 - ReproTech, LLC
TRACTUS Launched as Comprehensive Solution to FDA UDI Final Rule
Medical devices are an integral part of the health care system. Advances in devices and implants has led to a longer and improved quality of life for countless patients. However, not all interactions with medical devices have proven trouble-free. Recalls, Adverse events, and post-market... - August 07, 2015 - Matrix Medical Tracking Systems
Motorcyclists in Three States Help Children with Brain Tumors
Ride for Kids motorcyclists gathered in three states over the weekend and raised $103,927 for the Pediatric Brain Tumor Foundation. The events in Michigan, New York and Pennsylvania honored 25 local brain tumor survivors on Aug. 2: Andrea, Andrew, Angel, Annabelle, Bo, Catie, Gianna, James, Jon,... - August 05, 2015 - Pediatric Brain Tumor Foundation
Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech
Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC
New Product Launched to Safeguard Patients from Counterfeit Medical Implants and Improved Recall Accuracy
New technology tracks medical implants; guards against counterfeits and offers ability to match recalls with patients. Matrix Medical announces the comprehensive TRACTUS solution to fill a much needed industry need. Product is fully in adherence to the GUDID and UDI requirements laid out by FDA. - July 29, 2015 - Matrix Medical Tracking Systems
Riders in Midwest, South Raise Funds for the PBTF
From the southern hills to the Midwestern plains, Ride for Kids motorcyclists combined to raise more than $90,000 for the Pediatric Brain Tumor Foundation on July 26. More than 300 participants attended the East Tennessee and Kansas City Ride for Kids events to honor their local brain tumor... - July 29, 2015 - Pediatric Brain Tumor Foundation
New Technology from MR Solutions Could Mean That Our Children Can Still Have Helium Party Balloons in the Future
Helium filled party balloons could be relegated to the past if the supply of helium dwindles, but MR Solutions, the world technology leader in preclinical MRI systems could be riding to the rescue with scanners that do not require liquid helium. - July 25, 2015 - MR Solutions
Speaking of NEC Podcast Featuring Dr. Naveed Hussain Launches July 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - July 24, 2015 - The Morgan Leary Vaughan Fund, Inc.
MiTeGen Announces Mutual Distribution Agreements with Rigaku Reagents
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with Rigaku Reagents. - July 23, 2015 - MiTeGen, LLC
NanoHybrids Enters into Distribution Agreement with Eikonix
NanoHybrids Inc, a biotechnology company based in Austin, Texas, and Eikonix, UK, a distributor of imaging systems and contrast agents announced today that they have entered into an agreement that adds NanoHybrids’ premium gold nanoparticles to Eikonix's extensive offering of scientific... - July 23, 2015 - NanoHybrids
Fertility Preservation Network Welcomes Raleigh, North Carolina Area Facility
Program greatly extends access to fertility preservation services. - July 23, 2015 - ReproTech, LLC
Global Biosimilars Market, 2015-2025
Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment. - July 22, 2015 - Roots Analysis
Ride for Kids Crosses Borders to Raise Funds for PBTF
Ride for Kids motorcyclists rode in three states to raise $392,428 for the Pediatric Brain Tumor Foundation over the weekend. Riders in Minnesota, New York and Wisconsin honored 27 brain tumor survivors on July 19: Alyona, Amanda, April, Beckett, Carra, Catrina, Connor, Dominic, Emily, Hunter,... - July 22, 2015 - Pediatric Brain Tumor Foundation
The Journal of Headache and Pain Reports That electroCore’s Non-Invasive Vagus Nerve Stimulation (nVNS) Treatment is Effective in Migraines
-- 65% of the study participants reported pain relief(1) by 2 hours after treatment, with 56% already reporting pain relief by one hour, and 35% were pain free by one hour -- Authors stated that nVNS was safe, well tolerated and effective in many patients and may reduce medication overuse and... - July 17, 2015 - electroCore
Non-Tyrosine Kinase Inhibitors Market to Witness 9% Annualized Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering. The report provides a comprehensive analysis of the current market landscape and the future outlook of kinase inhibitors not specifically targeting tyrosine... - July 16, 2015 - Roots Analysis
MR Solutions Displays World-Leading Cryogen-Free Magnet Technology at ISMRM and SNMMI Conferences
Delegates visiting MR Solutions’ new exhibition stand at ISMRM 2015 and SNMMI 2015, in June 2015, were thrilled to see the company’s 3T, 4.7T and 7T MRI cryogen-free magnet technology for preclinical imaging. The preclinical MRI systems provide superior soft tissue contrast and high spatial resolution and can now be placed inside a Class 3 or 4 laboratory as external venting is no longer needed. - July 15, 2015 - MR Solutions
Ohio Motorcyclists Raise Funds for the PBTF
Motorcyclists from the Buckeye State banded together for children fighting brain tumors at the 24th Marysville Ride for Kids over the weekend. The July 11 event, which benefited the Pediatric Brain Tumor Foundation, honored local brain tumor survivors Erin, Jared, Naomi and Seth as Ride for Kids... - July 15, 2015 - Pediatric Brain Tumor Foundation
Human Growth Foundation Hosts 3rd Annual Walk for Kids Growth-LA on December 5th
Human Growth Foundation will host its 3rd Annual Walk for Kids Growth-LA event on Saturday, Dec. 5, 2015. - July 10, 2015 - Human Growth Foundation
GenToX is Now Offering Inherited Cancer Testing
Industry Leader in Pharmacogenomics is now offering inherited cancer screenings for patients to enhance their personalized medical testing services. - July 10, 2015 - GenToX
Companion Diagnostics Market to Grow at 22.9% Over the Next Decade, Predicts Roots Analysis
Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing market, including market forecasts for the period 2014-2024. Shefali Asija, the principal analyst... - July 09, 2015 - Roots Analysis
Pharmaceutical Anti-Counterfeiting Technologies Market
The problem of counterfeit products has been a common challenge to all the industries across the globe. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. This field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. - July 06, 2015 - Roots Analysis
Immune Checkpoint Inhibitors Market to Witness 24.1% Annualised Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of "Immune Checkpoint Inhibitors Market - 2014 - 2024" report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4, PD-1, PD-L1 and several novel immune checkpoint inhibitors (IDO-1, IDO-2, KIR, OX40, CD70,... - July 05, 2015 - Roots Analysis
HPAPIs and Cytotoxic Drugs Manufacturing Market to Evolve Rapidly, Reports Roots Analysis
Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market. It identifies various CMOs active in this space,... - July 04, 2015 - Roots Analysis
Rare Diseases: Market Opportunities Predicted by Roots Analysis
The report provides a comprehensive study of the pipeline drugs being developed for rare diseases by several top pharmaceutical firms. - July 03, 2015 - Roots Analysis
ALPCO and Cisbio US, Inc. Announce Sales and Distribution Agreement
Starting on July 1, Cisbio US, Inc. will have exclusive access to ALPCO's colorimetric and STELLUX® Chemiluminescent Diabetes and Obesity products. - July 01, 2015 - ALPCO
Northern Indiana Motorcyclists Unite for Kids
Motorcyclists showed their support for children with brain tumors by raising $53,920 for the Pediatric Brain Tumor Foundation on June 28. More than 200 participants gathered for the Northern Indiana Ride for Kids in South Bend to honor brain tumor survivors Adler, Daniel, Hannah, Jayden, Jennifer... - July 01, 2015 - Pediatric Brain Tumor Foundation